FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896778041> ?p ?o ?g. }

• W2896778041 endingPage "280" @default.
• W2896778041 startingPage "275" @default.
• W2896778041 abstract "This study evaluates the biological effects of naringin (NAR) joint bone morphogenetic protein (BMP)-2 on the proliferation, alkaline phosphatase (ALP) activity, and expression of osteoblastogenic genes, such as Runt-related transcription factor 2 (Runx2), collagen Ⅰ (ColⅠ), ALP, and osteocalcin (OCN) of pre-osteoblasts.Three different NAR concentrations (10, 100, and 1 000 μmol·L⁻¹) were applied, alone or combined with BMP-2(50 ng·mL⁻¹), to restore the osteoblastogenesis of pre-osteoblasts (MC3T3-E1 cell line). Cell numbers (proliferation) were evaluated at first, fourth, and seventh days by Alamar blue assay. ALP activity and the expression of osteoblastogenic genes, such as Runx2, ColⅠ, ALP, and OCN were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) at fourth and seventh day.Stimulation by NAR alone and in combination with BMP-2 for 1 day and 4 days could promote cell proliferation, which peaked at a concentration of 100 μmol·L⁻¹ NAR combined with BMP-2 could promote cell proliferation significantly (P<0.05). Stimulation by NAR alone and in combination with BMP-2 for 4 and 7 days could promote ALP activity and bone-related gene(ALP, OCN, Runx2, ColⅠ) expression. ALP expression was significantly promoted after stimulation of 100 μmol·L⁻¹ NAR and BMP-2 (P<0.05).NAR exhibits promising potential for improving MC3T3-E1 proliferation and differentiation, and appropriate concentrations of NAR and BMP-2 show synergistic effect. .目的 研究柚皮苷（NAR）联合骨形态发生蛋白（BMP）-2对体外培养的成骨前体细胞MC3T3-E1增殖、碱性磷酸酶（ALP）活性及成骨相关基因ALP、骨钙素（OCN）、成骨特异性转录因子（Runx2）、Ⅰ型胶原（ColⅠ）表达的影响。方法 以成骨细胞株MC3T3-E1为体外药效的试验模型，通过Alamar blue法检测第1、4和7天3种不同浓度NAR（10、100和1 000 μmol·L⁻¹）单独作用以及分别与50 ng·mL⁻¹ BMP-2联合诱导对MC3T3-E1细胞增殖能力的影响。同时在第4天和7天测定成骨细胞内ALP活性，采用实时定量聚合酶链反应（qRT-PCR）检测成骨相关基因ALP、OCN、Runx2、ColⅠ的表达。结果 单纯NAR刺激及联合BMP-2刺激能够促进细胞增殖，在NAR浓度为100 μmol·L⁻¹时达到高峰（P<0.05），且该浓度NAR与BMP-2联合作用时增殖效果大于两者单独作用（P<0.05）。单纯NAR刺激及联合BMP-2刺激4 d和7 d时均能促进细胞ALP活性，100 μmol·L⁻¹ NAR与BMP-2联合作用时ALP活性最强（P<0.05）。100~1 000 μmol·L⁻¹的NAR单独及联合作用在不同程度上能促进ALP、OCN、Runx2、ColⅠ成骨相关基因表达。结论 NAR能有效促进成骨细胞株MC3T3-E1增殖、分化，且适宜浓度的NAR和BMP-2有协同和促进作用。." @default.
• W2896778041 created "2018-10-26" @default.
• W2896778041 creator A5010218596 @default.
• W2896778041 creator A5014950631 @default.
• W2896778041 creator A5028401090 @default.
• W2896778041 creator A5050772776 @default.
• W2896778041 creator A5086249651 @default.
• W2896778041 creator A5088472807 @default.
• W2896778041 date "2017-06-01" @default.
• W2896778041 modified "2023-09-27" @default.
• W2896778041 title "[Effect of naringin combined with bone morphogenetic protein-2 on the proliferation and differentiation of MC3T3-E1 cells]." @default.
• W2896778041 cites W1545865644 @default.
• W2896778041 cites W1965875788 @default.
• W2896778041 cites W1971912573 @default.
• W2896778041 cites W1993669054 @default.
• W2896778041 cites W1997480784 @default.
• W2896778041 cites W1998696289 @default.
• W2896778041 cites W1998728165 @default.
• W2896778041 cites W2015050458 @default.
• W2896778041 cites W2017120735 @default.
• W2896778041 cites W2024161643 @default.
• W2896778041 cites W2025059729 @default.
• W2896778041 cites W2031013672 @default.
• W2896778041 cites W2032772487 @default.
• W2896778041 cites W2063142742 @default.
• W2896778041 cites W2085364664 @default.
• W2896778041 cites W2113704955 @default.
• W2896778041 cites W2114528551 @default.
• W2896778041 cites W2132309525 @default.
• W2896778041 cites W2142590601 @default.
• W2896778041 cites W2154066806 @default.
• W2896778041 cites W2156075512 @default.
• W2896778041 cites W2394692769 @default.
• W2896778041 cites W2399215471 @default.
• W2896778041 doi "https://doi.org/10.7518/hxkq.2017.03.009" @default.
• W2896778041 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7030434" @default.
• W2896778041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28675012" @default.
• W2896778041 hasPublicationYear "2017" @default.
• W2896778041 type Work @default.
• W2896778041 sameAs 2896778041 @default.
• W2896778041 citedByCount "4" @default.
• W2896778041 countsByYear W28967780412018 @default.
• W2896778041 countsByYear W28967780412019 @default.
• W2896778041 countsByYear W28967780412020 @default.
• W2896778041 crossrefType "journal-article" @default.
• W2896778041 hasAuthorship W2896778041A5010218596 @default.
• W2896778041 hasAuthorship W2896778041A5014950631 @default.
• W2896778041 hasAuthorship W2896778041A5028401090 @default.
• W2896778041 hasAuthorship W2896778041A5050772776 @default.
• W2896778041 hasAuthorship W2896778041A5086249651 @default.
• W2896778041 hasAuthorship W2896778041A5088472807 @default.
• W2896778041 hasConcept C104317684 @default.
• W2896778041 hasConcept C125349252 @default.
• W2896778041 hasConcept C131075544 @default.
• W2896778041 hasConcept C134018914 @default.
• W2896778041 hasConcept C153911025 @default.
• W2896778041 hasConcept C160160445 @default.
• W2896778041 hasConcept C181199279 @default.
• W2896778041 hasConcept C185592680 @default.
• W2896778041 hasConcept C202751555 @default.
• W2896778041 hasConcept C24998067 @default.
• W2896778041 hasConcept C2776363554 @default.
• W2896778041 hasConcept C2776432469 @default.
• W2896778041 hasConcept C2777335409 @default.
• W2896778041 hasConcept C2778260815 @default.
• W2896778041 hasConcept C30352789 @default.
• W2896778041 hasConcept C31507581 @default.
• W2896778041 hasConcept C43617362 @default.
• W2896778041 hasConcept C55493867 @default.
• W2896778041 hasConcept C62112901 @default.
• W2896778041 hasConcept C86803240 @default.
• W2896778041 hasConcept C95444343 @default.
• W2896778041 hasConceptScore W2896778041C104317684 @default.
• W2896778041 hasConceptScore W2896778041C125349252 @default.
• W2896778041 hasConceptScore W2896778041C131075544 @default.
• W2896778041 hasConceptScore W2896778041C134018914 @default.
• W2896778041 hasConceptScore W2896778041C153911025 @default.
• W2896778041 hasConceptScore W2896778041C160160445 @default.
• W2896778041 hasConceptScore W2896778041C181199279 @default.
• W2896778041 hasConceptScore W2896778041C185592680 @default.
• W2896778041 hasConceptScore W2896778041C202751555 @default.
• W2896778041 hasConceptScore W2896778041C24998067 @default.
• W2896778041 hasConceptScore W2896778041C2776363554 @default.
• W2896778041 hasConceptScore W2896778041C2776432469 @default.
• W2896778041 hasConceptScore W2896778041C2777335409 @default.
• W2896778041 hasConceptScore W2896778041C2778260815 @default.
• W2896778041 hasConceptScore W2896778041C30352789 @default.
• W2896778041 hasConceptScore W2896778041C31507581 @default.
• W2896778041 hasConceptScore W2896778041C43617362 @default.
• W2896778041 hasConceptScore W2896778041C55493867 @default.
• W2896778041 hasConceptScore W2896778041C62112901 @default.
• W2896778041 hasConceptScore W2896778041C86803240 @default.
• W2896778041 hasConceptScore W2896778041C95444343 @default.
• W2896778041 hasIssue "3" @default.
• W2896778041 hasLocation W28967780411 @default.
• W2896778041 hasOpenAccess W2896778041 @default.
• W2896778041 hasPrimaryLocation W28967780411 @default.
• W2896778041 hasRelatedWork W1124487740 @default.

• next